LiveStay informed about what's happening at Nova
#drugR&D #insilicomedicine #systemsbiology #biomodeling #machinelearning
June 7, 2018
Dr Riad KAHOUL, MD, PhD, biostatisticien and biomodelizer in Nova team, will give a talk at the 10th edition of the event organized by AFCRO
June 19, 2018
François-Henri BOISSEL, CEO, will be the moderator fo the panel discussion on “In silico medicine” at the 37 ºC “Digitalising health” Life science Technology & Business Conference, Stavanger Forum, Norway
PAGE 2018 Meeting: An in silico model of Hepatitis B virus predicts patients response to ENYO PHARMA’s drug candidate EYP001
NOVADISCOVERY presents first results from the in silico component of the exploratory clinical program initiated by ENYO Pharma on EYP001, a non-bile acid FXR receptor agonist currently in phase 1b trial for the treatment of chronic Hepatitis B.